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expected LOS compared to baseline (OR  0.791, p  0.01). Among patients who did 
exceed the expected LOS, Floseal patients did so at a reduced rate (IRR  0.891, p 
0.01). Surgical use was not associated with any signiﬁ cant difference from baseline, 
while Gelfoam use showed a slightly higher associated likelihood of exceeding
expected LOS (OR  1.099, p  0.05). CONCLUSIONS: Floseal use was associated
with lower than expected LOS in cardiac surgery. Given small proﬁ t margins achieved 
by hospitals today, further assessment is warranted to distinguish products with favor-
able outcomes.
HEALTH CARE INTERVENTIONS – Patient-Reported Outcomes Studies
PHC6
SUBJECTS SUFFERING FROM HALITOSIS: IMPACTS OF THE TREATMENT
Taieb C
Pierre Fabre, Boulogne, France
OBJECTIVES: Assess the impact in terms of quality of life 9QoL) of ALIBI (Extract 
of green tea & Parsley essential oil) in patients suffering from halitosis. METHODS:
An observational, longitudinal and prospective assessment, carried out in a pharmacy 
on subjects suffering from halitosis who were seeking an immediate remedy. The 
questionnaire used was the Halitosis Quality of Life Questionnaire (HQLQ), the only 
validated questionnaire regarding halitosis. RESULTS: A total of 311 subjects suffer-
ing from halitosis were included. The average age was 45.07 o 15.99 years. The sex 
ratio was 29.90% of men vs 70.10% of women. Also, 71.06% of the subjects exer-
cised a professional activity. Seventy percent claimed they brushed their teeth after
each meal; 44.23 of the subjects used accessories (26% inter-dental toothbrushes, 29%
dental ﬂ oss and 11% tongue scrapers). Sixty-six percent stated they became aware of 
halitosis themselves, 30% from a third party. Halitosis had been present for approxi-
mately 5 years; 11% had consulted only their halitosis. The overall HQ22 score was 
14.68 o 7.86, after 7 days of treatment by Extract of green tea & Parsley essential 
oil, the score was 10.23 o 8.00. The improvement was statistically signiﬁ cant (p 
0.001). The evolution of each of the 4 dimensions (“daily life”, “mental”, “emo-
tional”, “social and work”) also improved. The everyday life score changed from 2.95
o 2.10 to 1.89 o 1.92, the Emotional score changed from 2.46 o 2.10 to 1.81 o 1.95,
the Mental score changed from 4.45 o 2.75 to 3.22 o 2.80 and the Social & Work 
dimension score changed from 4.92 o 2.50 to 3.54 o 2.60 CONCLUSIONS: Since
using Extract of green tea & Parsley essential oil, 90% of subjects suffering from hali-
tosis have experienced an improvement in their everyday lives, 83% feel more at ease 
in their cultural and social activities. These results conﬁ rm the improvement of QoL 
among subjects suffering from halitosis after 7 days of treatment.
PHC7
DEVELOPMENT AND VALIDATION OF SPECIFIC HEALTH RELATED 
QUALITY OF LIFE QUESTIONNAIRE FOR HALITOSIS: THE HALITOSIS
QUALITY OF LIFE QUESTIONNAIRE (HQLQ)
Taieb C1, Maso H2
1Pierre Fabre, Boulogne, France, 2PFOC, CASTRES, France
OBJECTIVES: Halitosis or bad breath is a chronic condition affecting a large fraction 
of the adult population. The aim of this study was to develop and validate a halitosis-
speciﬁ c quality of life questionnaire for adults. METHODS: Development and valida-
tion of the questionnaire have been performed using the standardized multi-step
method. RESULTS: A total of 169 eligible patients answered both questionnaires at
day 0. Sixty-three did the same a second time at day 7. The initial pool of questions 
comprised 24 items. Two items were deleted, the ﬁ rst was considered redundant and 
the due to ceiling effect, i.e., a ceiling effect means that most patients are not worried 
by a particular item. This resulted in a questionnaire of 22 items. Eleven items were 
allocated to each of the two domains. None of the items allocated to a domain showed 
a signiﬁ cantly higher correlation with the total score of the other domain. CONCLU-
SIONS: The ﬁ nal version of the HQLQ contains 22 items covering 2 domains of 
quality of life assessment, namely “social and daily life activities” and “personal
domain.” The questionnaire is designed for self-administration. It showed both good
reliability and construct validity. The intraclass correlation indicates good responsive-
ness of the HQLQ. To be valid, a questionnaire needs to be easily understood and 
completed by the population concerned. In summary, the health-related Quality of 
Life Questionnaire for halitosis is a valid instrument for use in adults complaining of 
bad breath. It is the ﬁ rst ever to have been developed with this speciﬁ c aim.
HEALTH CARE INTERVENTIONS – Health Care Use & Policy Studies
PHC8
REGIONAL DISPARITIES AND ECONOMIC OUTCOMES ASSOCIATED
WITH MINIMALLY INVASIVE AND CONVENTIONAL SURGERIES OF THE
CHEST, ABDOMEN, AND PELVIS
Moore M1, Hochheiser L2, Gunnarsson C3, Ladapo J4, Borah B5
1Ethicon Endo-Surgery, Inc., Cincinnati, OH, USA, 2University of Vermont, Jackson, WY, USA, 
3S2 Statistical Solutions, Inc, Cincinnati, OH, USA, 4Beth Israel Deaconess Medical Center, 
Boston, MA, USA, 5i3 Innovus, Eden Prairie, MN, USA
OBJECTIVES: Rising health care expenditures remains a major policy concern. 
Research suggests that regional variations in spending contribute to this crisis.
Regional variations in the utilization of minimally invasive and conventional
approaches to common surgeries is an extension of this paradigm, and likely con-
tributes to disparities in health outcomes and expenditures across the nation. This
study examines these factors through the lens of the following procedures: colectomy, 
laparoscopic and vaginal hysterectomy, esophagogastric fundoplasty, cholecystectomy, 
appendectomy, bariatric surgery, breast biopsy, ventral hernia repair, and lung reduc-
tion surgery. METHODS: We performed a retrospective cohort analysis using 
medical and pharmacy claims data from a large national health plan. Data on patient
age, geographic residence, and severity were extracted. Geographic regions were cat-
egorized as West, Midwest, Northeast and South. Outcomes of interest included 
intraoperative and post-operative complications, length of hospital stay, infection rates 
and associated antibiotic utilization, and readmission rates. Total expenditures for
health care utilization directly associated with a patient’s surgery were estimated.
Generalized linear models were constructed using a gamma distribution and log link 
function to estimate the effect of surgical approach on major outcomes while adjusting 
for other factors. RESULTS: Regional variations in utilization of laparoscopic and
open surgeries are most pronounced for colectomy, hysterectomy, and bariatric
surgery. Smaller but still signiﬁ cant variations in the utilization of minimally invasive 
and conventional esophagogastric fundoplasty, appendectomy, and breast biopsy were 
also observed. Colectomy, vaginal hysterectomy, esophagogastric fundoplasty, chole-
cystectomy, appendectomy, breast biopsy, and lung reduction surgery were associated 
with lower follow-up health care expenditures when a minimally invasive route was 
used. CONCLUSIONS: Signiﬁ cant regional variations in the utilization of minimally
invasive and conventional approaches to common surgeries exist in the United States.
To the extent that, surgical approach impacts infection risk, complications, length of 
stay, and other metrics, these variations contribute to disparities in health outcomes
and expenditures.
MUSCULAR-SKELETAL DISORDERS – Clinical Outcomes Studies
PMS1
INCREASED STANDARDIZED MORTALITY RATIO IN WORKERS WITH 
PERMANENT OCCUPATIONAL DISABILITY OF LOWER LIMB: 
A FOLLOW-UP STUDY OF 21 YEARS
Lin SH1, Lee HY1, Chang YY1, Jang Y1, Chen PC1, Wang JD2
1National Taiwan University Hospital, Taipei, Taiwan, 2National Taiwan University, College of 
Public Health, Taipei, Taiwan
OBJECTIVES: This study intends to determine if there is increased mortality for dif-
ferent causes among workers with permanent lower limb occupational disability. 
METHODS: We collected all cases of permanent occupational disability from the 
database of compensation claim of Bureau of Labor Insurance between 1986 and 
2006, which were linked with the national mortality registry to obtain the person-
years at risk for different calendar periods. The standardized mortality ratios (SMR) 
for workers with permanent disability of upper and lower limbs were calculated to
estimate the risk of mortality due to different causes in comparison with the general 
population of Taiwan. The software package of LTAS established by the National
Institute of Occupational Safety and Health of the United States was employed for
the above calculation. RESULTS: We found signiﬁ cantly higher SMR in the following 
causes of death for workers sustained a permanent occupational disability : Gastroin-
testinal cancers (SMR  1.28, 95% conﬁ dence interval (CI)  1.021.59), benign 
tumor(SMR  7.38, 95% CI  3.1914.54), diabetes mellitus (SMR  2.55, 95% 
CI  1.923.31), hypertension and stroke (SMR  1.42, 95% CI  1.06 1.86), suicide 
(SMR  1.92, 95% CI  1.192.93), injury (SMR  1.88, 95% CI  1.222.78), 
respiratory diseases (SMR  2.09, 95% CI  1.542.78), the digestive system diseases 
(SMR  1.36, 95% CI  1.021.77), and chronic kidney diseases (SMR  2.48, 95% 
CI  1.473.92). Workers suffering from permanent disability of upper limbs only
showed an increased SMR for digestive system. CONCLUSIONS: Workers with per-
manent lower limb occupational disability have higher risks of digestive cancer, injury, 
suicides, diabetes, and vascular diseases, which might be related to a general lack of 
exercise and should be considered in the process of rehabilitation and/or health promo-
tion for these populations.
PMS2
GOUT AND THE RISK OF ACUTE MYOCARDIAL INFARCTION AMONG
ELDERLY WOMEN
De Vera MA1, Rahman MM2, Bhole V2, Rankin J2, Aghajanian J2, Kopec J2, Choi HK1
1UBC School of Population & Public Health, Vancouver, BC, Canada, 2Arthritis Research
Centre of Canada, Vancouver, BC, Canada
OBJECTIVES: Gout is a common inﬂ ammatory arthritis associated with hyperurice-
mia. Despite the substantial prevalence of gout among ageing women, little is known 
about associated cardiovascular risks in this population. Previous studies that have 
shown an association between gout and acute myocardial infarction (AMI) have been
limited to men. Our objective was to evaluate the association between gout and non-
fatal AMI among elderly women, aged q65 years, and compare ﬁ ndings in men. 
METHODS: We conducted a case control study nested within a population-based 
gout cohort in the British Columbia Linked Health Database. Over a 12-year follow-
up, we identiﬁ ed incident cases of nonfatal AMI from hospitalization data and 
matched with 5 controls according to age, gender, and length of medical record. Deﬁ ni-
tions of exposure and outcome were physician-entered ICD-9 codes. Conditional 
logistic regression models were used to estimate the association between gout and AMI 
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after adjusting for age, gender, gout treatment, comorbidities, and medication use.
RESULTS: We identiﬁ ed 4821 AMI cases of which 1410 were women. The adjusted
odds ratio (OR [95% CI]) of AMI among women with gout was 1.62 (1.21–2.16), 
higher than the adjusted OR for men (1.12 [0.99–1.26]; p-value for interaction 0.01). 
When we combined both women and men in our analyses, we found an overall 
adjusted OR of 1.15 (1.06–1.25). CONCLUSIONS: Using population-based data, we 
found a 62% increased risk for AMI among elderly women with gout, and a 15%
increased risk for elderly gout patients overall. The association between hyperurice-
mia, a known precursor to gout, and cardiovascular disease provides a potential 
explanation for our ﬁ ndings. Gender differences in serum uric acid levels and metabo-
lism may further explain the difference in risks between women and men. Findings 
provide support for the aggressive management of cardiovascular risk factors in gout
patients.
PMS3
COMPARISON OF 3 COMORBIDITY MEASURES AFFECTING PHYSICAL 
FUNCTION AND QUALITY OF LIFE FOR PATIENTS WITH ANKYLOSING
SPONDYLITIS
Gooch K1, Wong R2
1Abbott Laboratories, Abbott Park, IL, USA, 2Abbott Laboratories, Parsippany, NJ, USA
OBJECTIVES: In clinical studies, comorbidity measurement refers to assessment of 
total burden of illnesses across multiple health conditions unrelated to the patients’ 
disease under study. In non-randomized clinical studies and epidemiology studies,
adjustment for comorbidity is often undertaken to ensure outcomes are not directly
affected by comorbidities. This analysis compared 3 measurements of comorbidities
and their effects on physical function and quality of life with data from a randomized 
controlled trial of adalimumab in ankylosing spondylitis (AS). METHODS: Data
were derived from the Adalimumab Trial Evaluating Long-Term Efﬁ cacy and Safety
in AS (ATLAS). Comorbidity indices at baseline were calculated as Chronic Disease
Score (CDS), number of separate prescription medications (prescription count), and
number of concurrent illnesses (concurrent illness count). Medications taken speciﬁ -
cally for the treatment of AS were excluded from the CDS and prescription medication 
count calculations. Univariate associations between each of the 3 indices and a physi-
cal function index (SF-36 PCS) and AS disease-speciﬁ c quality of life (ASQOL) at 
Week 12 were assessed. Correlations with each comorbidity measurement were ascer-
tained. Model selection (Alkaike’s Information Criterion [AIC]) was used to identify 
the best comorbidity measure for predicting SF-36 PCS and ASQOL. RESULTS: A 
total of 315 patients were included in the analysis. Their mean age was 42.2 years,
and most were male (74.9%). At the univariate level, all 3 indices were signiﬁ cant 
predictors of SF-36 PCS score (p  0.02), However, only CDS and prescription medica-
tion count were signiﬁ cantly associated with ASQOL at Week 12. All 3 indices were
well-correlated with each other (range 0.750–0.917). The AIC model demonstrated 
that CDS was the best predictor of SF-36 PCS and ASQOL. Prescription count was 
the second-best ranked measure for both outcomes. CONCLUSIONS: The CDS is a
suitable measure for comorbidity adjustment in examining physical function and 
quality of life for AS patients.
PMS4
RISK FACTORS FOR INCIDENT GOUT AMONG WOMEN: 
A PROSPECTIVE STUDY
Bhole V1, De Vera MA2, Rahman MM1, Choi HK2
1Arthritis Research Centre of Canada, Vancouver, BC, Canada, 2UBC School of Population & 
Public Health, Vancouver, BC, Canada
OBJECTIVES: Despite increasing incidence and substantial prevalence of gout among 
women, particularly among elderly, no prospective data on the risk factors for gout 
are available among women. We prospectively evaluated purported risk factors for
the risk of incident gout among women and compared them with men. METHODS:
Using data from the Framingham Heart Study, we prospectively examined over a 52-
year period (1948–2001) the relation between prior serum uric acid levels and the risk 
of incident gout in 2,470 women and 1,951 men. We used Cox proportional hazards 
models to estimate the relative risk for incident gout by uric acid level after adjusting
for age, body mass index, blood glucose level, blood cholesterol level, hypertension,
use of diuretics, alcohol consumption, educational level and menopausal status.
RESULTS: Over a 28-year median follow-up, we documented 304 incident cases of 
gout, 104 among women. The incidence rates of gout increased with increasing serum 
uric acid levels, similar to men. For uric acid levels of 5.0, 5.0–5.9, 6.0–6.9, 7.0–7.9 
and q8.0 mg/dL the incidence rates of gout per 1000 person-years were 0.81, 1.42, 
1.83, 6.75, and 13.09, respectively (p for trend 0.0001). The multivariate relative 
risk (95% CI) for incident gout for every 1.0 mg/dL increase in serum uric acid level 
was 1.57 (1.38–1.78) among women and 1.52 (1.36–1.71) among men. Other signiﬁ -
cant predictors of gout in women were age, obesity, hypertension, blood glucose level 
and diuretic use. CONCLUSIONS: These prospective data indicate that higher levels 
of serum uric acid increase the risk of gout among women in a graded manner, similar 
to men, and support the notion that serum uric acid is a reliable surrogate marker
and precursor of incident gout among women as well. Age, obesity, hypertension, 
blood glucose level and diuretic use were associated with the risk of incident gout
among women.
PMS5
FACTORS INFLUENCING THE LENGTH OF STAY AND TOTAL CHARGES
FOR PEDIATRIC PATIENTS DIAGNOSED WITH OSTEOMYELITIS
Dorwart JL
University of Louisville, Louisville, KY, USA
OBJECTIVES: Osteomyelitis is an infection of the bone caused by an untreated injury.
Osteomyelitis can also come from an infection from another part of the body, such 
as a urinary tract infection that can spread to the bone through the blood. The purpose 
of this study is to determine what factors can inﬂ uence a pediatric patient’s stay in the
hospital when the patient has a diagnosis of osteomyelitis. METHODS: In order to
look at the length of stay and total charges for the patient’s stay in the hospital, we
used table analysis, summary statistics, one way frequency, kernel density, logistic
regression, and linear regression. Kernel density examines the entire population dis-
tribution. Logistic regression gives a prediction of the probability of occurrence. Linear
regression analyzes the effect of one variable on another. The data were taken from
the 2005 National Inpatient Sample with a total of 3972 patients; 1971 have osteo-
myelitis and the remaining 2001 patients form a control group. RESULTS: The 
average length of stay in the hospital was about eight days. For patients who had 
osteomyelitis, the peak value of total charges was around $10,000, and those who did
not have the disease had a peak value of total charges of around $5,000. The variables 
that are signiﬁ cant on total charges are died, length of stay, race, bacterial infection, 
episodic mood disorders, arthrocentesis, magnetic resonance, incision, excision, and 
division, other incision with drainage, injection of antibiotic, and spinal tap. CON-
CLUSIONS: Generally, patients who have osteomyelitis have a longer hospital stay
and a higher bill compared to those that do not. The procedures performed on a 
patient inﬂ uence their length of stay and total charges. Length of stay is inﬂ uenced
more by invasive procedures and total charges are inﬂ uenced on length of stay and 
the number of procedures performed.
PMS6
DEVELOPMENT OF TESTS FOR DIAGNOSIS OF RHEUMATOID
ARTHRITIS
Schiff L1, Foster T1, Creeden J2, Gartemann J2, Hsieh J2, Pashos CL1
1Abt Bio-Pharma Solutions, Inc., Lexington, MA, USA, 2Roche Diagnostics, Ltd, Rotkreuz, 
Switzerland
OBJECTIVES: New therapeutic options for rheumatoid arthritis (RA) have shifted
the focus of treatment to early, aggressive intervention aimed at preventing further
joint damage. However, early diagnosis has proved challenging, and recent efforts have
been made to identify new diagnostic tests. We systematically reviewed the literature 
to assess the current status of tests for early diagnosis of RA. METHODS: We searched 
English-language MEDLINE-indexed publications in the 5 years prior to August 2008 
concerning tests and biomarkers for early diagnosis of RA. We also searched non-
MEDLINE-indexed sources such as organization websites, meeting abstracts, and
governmental publications using the same keywords. RESULTS: We identiﬁ ed 94 
primary studies from MEDLINE pertaining to tests or biomarkers for early diagnosis 
of RA. Non-MEDLINE sources yielded an additional 56 articles for a total of 150 
reviewed for this study. In practice, no single test has proved sufﬁ ciently sensitive and 
speciﬁ c for the diagnosis of RA. Tests currently in use, including the acute phase bio-
markers erythrocyte sedimentation rate and C-reactive protein and the autoantibody 
rheumatoid factor (RF), are relatively nonspeciﬁ c for RA. Recent efforts have focused 
on identifying new biomarkers with greater RA speciﬁ city. These include many auto-
antibodies, immune system biomarkers, and biomarkers of collagen breakdown and
bone erosion. The autoantibody anti-cyclic citrullinated peptide (anti-CCP) offers high 
speciﬁ city, but lower sensitivity than RF. Newer-generation anti-CCP assays provide
improved sensitivity over ﬁ rst-generation anti-CCP assays, but sensitivity still pre-
cludes their use as sole diagnostic tests for RA. The clinical utility of anti-CCP tests 
can be improved by combining with other assays such as RF, and provide particular 
value in predicting the development of persistent and/or erosive RA. CONCLUSIONS:
Newer generations of the autoantibody anti-CCP assay offer high speciﬁ city for RA 
and appear promising as a diagnostic test in combination with other tests with greater 
sensitivity.
PMS7
A 2-YEAR EVALUATION OF INFLIXIMAB’S EFFECTIVENESS IN THE 
TREATMENT OF RHEUMATOID ARTHRITIS IN ACTUAL PRACTICE
Tang B1, Rahman M2, Naim A1, Meissner B3, Dehoratius R1, Piech CT1
1Centocor Ortho Biotech Services, LLC, Horsham, PA, USA, 2Ortho Clinical Diagnostics, 
Raritan, NJ, USA, 3Xcenda, Palm Harbor, FL, USA
OBJECTIVES: To evaluate the long-term effectiveness of inﬂ iximab in the treatment
of rheumatoid arthritis (RA) in the actual practice setting. METHODS: A retrospective
chart review was conducted in six rheumatology clinics across the US. RA patients 
with a ﬁ rst inﬂ iximab encounter occurring between 2002 and 2004 were identiﬁ ed. 
Patients were required to have a minimum of 12-months of continuous records prior 
to the index inﬂ iximab date and were followed for up to 24-months after therapy
initiation. Effectiveness was deﬁ ned as reductions in joint pain, swelling, stiffness, and 
fatigue scores of 1 point (range from 0 to 10). Overall clinical improvement was
measured as a combination of pain, swelling, stiffness, and fatigue scores. Wilcoxon
Signed-Rank Tests were performed to test if there were statistically signiﬁ cant changes
from baseline. Also, biomarker test results, C-reactive protein (CRP) and erythrocyte 
sedimentation rate (ESR), were collected and compared to the baseline results.
RESULTS: A total of 266 inﬂ iximab patients were identiﬁ ed (72.9% female; average
